Research reveals Londoners are the most anxious and have the worst work-life balance in the UK and many would choose to use CBD oil rather than seeing their GP.
A five-year license has been issued to two companies allowing the cultivation and processing of medical cannabis products.
From the stories appearing about CBD and its near miraculous effects, to the pharmaceutical companies rushing to catch up, it seems everyone is taking about cannabidiol.
Ramya Sriram, manager at Kolabtree, explains why many patients in the UK still cannot access medical cannabis and how scientific communication and further research can lead to change.
Dr Mark Ware, Chief Medical Officer at Canopy Growth, provides an overview of the research that already exists around medicinal cannabis and explains why there is a need to educate clinicians further.
European Cannabis Holdings (ECH) has announced plans to open The Medical Cannabis Clinics in a step toward aiding patients living with a range of chronic conditions.
A survey by Rehab 4 Addiction using Facebook reveals more than 80% of people aged 55+ are contemplating asking their doctor about medicinal cannabis following the upcoming the change that’s due to kick in next week
Home secretary, Sajid Javid has announced that medicinal products that derive from cannabis will be made available on prescription by Autumn.
Dr. Alexander Natz and Dr. Oliver Sude, EUCOPE outline the role small to medium sized innovative companies can play in developing pharmaceutical research